Audrey O’Nan

Audrey entered the industry in 2003 and joined QCL in 2018 to establish the presence in the Biotechnology arena. She is experienced in the genomics and proteomics field with a focus on gene expression, post-translational modifications, DNA and RNA sequencing, and real-time PCR. Audrey’s emphasis has been on protein and enzymatic assays, cell-based assays, residual DNA testing, Microflow Imaging (MFI), and SDS-PAGE.